Completed

Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

NCT00735501

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Copenhagen S, Denmark

+1 additional location